Daprodustat

Spezifikationen

960539-70-2CAS-Nummer

691-659-9EG-Nummer

2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acidIUPAC-Name

C19H27N3O6Chemische Formel

393.4 g/molMolekulargewicht

Daprodustat; 960539-70-2; GSK1278863; GSK-1278863; JESDUVROQ; Duvroq; daprodustatum; JVR38ZM64B; N-((1,3-Dicyclohexylhexahydro-2,4,6-trioxopyrimidin-5-yl)carbonyl)glycine; DTXSID501337360; 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinan-5-yl)formamido]acetic acid; 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid; Glycine, N-((1,3-dicyclohexylhexahydro-2,4,6-trioxo-5-pyrimidinyl)carbonyl)-; N-[(1,3-Dicyclohexylhexahydro-2,4,6-trioxopyrimidin-5-yl)carbonyl]glycine; 2-((1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinan-5-yl)formamido)acetic acid; 2-((1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino)acetic acid; Glycine, N-[(1,3-dicyclohexylhexahydro-2,4,6-trioxo-5-pyrimidinyl)carbonyl]-; RefChem:59170; DTXCID001767752; GSK 1278863; Daprodustat (GSK1278863); (1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidine-5-carbonyl)glycine; Daprodustat [USAN:INN]; UNII-JVR38ZM64B; Daprodustat?; Jesduvroq (TN); Duvroq (TN); Daprodustat (Standard); DAPRODUSTAT [INN]; DAPRODUSTAT [JAN]; DAPRODUSTAT [USAN]; DAPRODUSTAT [WHO-DD]; Daprodustat; GSK1278863; Daprodustat (JAN/USAN/INN); GTPL8455; orb1223511; orb2281190; CHEMBL3544988; SCHEMBL21725048; CHEBI:229223; GLXC-07677; EX-A1121; BDBM50606586; HY-17608R; MFCD29924726; s8171; AKOS027439964; CCG-268574; CS-5453; DB11682; EBC-251095; SB19761; NCGC00496910-02; AC-30915; BG166670; HY-17608; MS-26596; DB-096637; NS00073632; D10874; BRD-K06455935-001-01-3; Q27076986; N-[(1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidin-5-yl)carbonyl]glycine; {[(1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidin-5-yl)carbonyl]amino}acetic acid; 2-(1,3-Dicyclohexyl-2,4,6-trioxohexahydropyrimidine-5-carboxamido)acetic acid; 2-[(1,3-dicyclohexyl-2,4,6-trioxo-hexahydropyrimidine-5-carbonyl)amino]acetic acidSynonyme